A subgenomic cDNA clone from hepatitis A virus strain HM175, composed of the last eight nucleotides of the 5' non-translated region and the first 2248 nucleotides of the coding sequence (P1 region), was inserted into a vector under the control of the T7 promoter. Restriction enzyme digestion at sites within the structural region and subsequent transcription in vitro yielded RNA products which were translated efficiently in rabbit reticulocyte lysates to produce proteins of the predicted sizes. The translation products were specifically precipitated with antipeptide antisera; these reactions were not affected by denaturation of the antigens by boiling in 1% SDS. The translated proteins were also precipitated by antivirion antisera, but recognition was totally abolished following denaturation. Thus antivirion antisera recognized conformation-dependent epitopes expressed on the translated products exclusively.
Introduction
Hepatitis A virus (HAV) is a hepatotropic picornavirus. It is endemic throughout the world, but is particularly prevalent in areas of poor sanitation. Although killed vaccines are now undergoing clinical trials, virus yields in vitro are generally low and no specific markers of attenuation have been described, making the production of a practical HAV vaccine difficult and expensive. On the basis of its morphological and biophysical characteristics, HAV was provisionally classified as an enterovirus, type 72 (Coulepis et al., 1982) . However, from recent studies it appears that HAV belongs to a separate genus within the Picornaviridae (Melnick, 1990) . Structurally, it is a 27 nm diameter icosahedral particle composed of a protein shell surrounding a positive-sense RNA genome of about 7480 nucleotides in length, polyadenylated at the 3' end (Cohen et al., 1987b) . It has a long 5' non-translated region (NTR) containing several AUG codons in addition to the one involved in the initiation of polyprotein translation. The genome is expressed as a single polyprotein which is cleaved to yield mature proteins; the structural protein precursor (P 1 region) starts near the N terminus of the polyprotein. The antigenic structure of the virus is highly conserved; for example there is no significant difference in the neutralization by polyclonal anti-HAV antiserum of an isolate derived from a human (HM175) and one obtained from a New World owl monkey (PA21) (Lemon & Binn, 1983) . Consistent with this antigenic stability, the amino acid sequences of the capsid polypeptides from several 0001-0127 © 1991 SGM strains of HAV are highly conserved, with over 97% amino acid sequence identity (Ticehurst et al., 1989) . The immunodominant neutralization sites of the virus are conformation-dependent and neutralizing monoclonal antibodies (MAbs) do not recognize virus proteins by Western blotting following separation by SDS-PAGE (Hughes et al., 1984) . Mapping studies by competitive binding with a panel of neutralizing MAbs have suggested that there is a dominant antigenic site, composed of a series of closely spaced, overlapping epitopes, on the virus (Stapleton & Lemon, 1987) . Selection of neutralization escape mutant viruses with MAbs has shown that substitution of amino acid 70 of VP3 (aspartic acid) with any of several other amino acids confers resistance to a wide range of antibodies (Ping et al., 1988) . The pressure for conservation of the virus capsid is evidenced by the rapid reversion of this mutation during passage under non-selective conditions in primate hosts (Lemon et al., 1990) .
Successful prophylactic protection against hepatitis A can be achieved by passive transfer of human immunoglobulin, even though the virus-neutralizing titre is very low (Stapleton et al., 1985) . Low levels of virusneutralizing and immunoprecipitating activity have been induced in rats with purified HAV capsid proteins, albeit after multiple immunization . Taken together, the absence of antigenic variation, the presence of a single major immunodominant site and the potential immunogenicity of isolated capsid polypeptides suggest that expression of the structural proteins of the virus by recombinant DNA techniques may be a profitable route to the production of a subunit vaccine against hepatitis A.
In this paper we describe the expression in vitro of subgenomic transcripts of HAV from constructs that lack the 5' NTR of the virus. The unprocessed structural fragments produced by these constructs were examined serologically to determine their native conformation and were found to mimic epitopes present on the mature virion.
Methods
Construction of recombinant HA V transcription vector. Using standard cloning procedures (Sambrook et al., 1989) , recombinant cDNA clones from cell culture-adapted p16 (Jansen et al., 1988) and wild-type (Ticehurst et al., 1983) variants of the HMI75 strain of HAV were assembled into a single plasmid construct (pHAVcHE2) containing bases 0 to 4610 of the sequence of the p 16 variant of HM 175. The XbaISad restriction fragment of pHAVcHE2, representing the coding region of the P1 structural protein, was subsequently inserted into the transcription vector pTZ-19R (USB) under control of the T7 promoter. The extreme 5' end of VP4, the putative initiating AUG and eight nucleotides of upstream HAV sequence were reconstructed using two synthetic oligonucleotides, by insertion at the SphI and XbaI sites. The sequence and construction of these inserts were checked by dideoxynucleotide sequencing (Sanger et al., 1977) . The resulting clone, pTZ-T1, contains the complete P1 sequence from HAV, except for 39 amino acids from the carboxy terminus of VP1, and is shown in Fig. 1 .
Synthesis of peptides and coupling to carrier protein.
Peptides were synthesized by the method of Houghten (1985) . They were coupled to keyhole limpet haemocyanin, through an additional cysteine at their C termini, using N-maleimidobenzoic acid N-hydroxysuccinimide ester (Liu et aL, 1979) .
Production of antipeptide and antivirion antisera. Dunkin-Hartley guinea-pigs were injected with approximately 50 ~tg coupled peptide or 2 ~tg sucrose gradient-purified virus in complete Freund's adjuvant, and boosted twice at monthly intervals with the same amount of peptide or virus in incomplete Freund's adjuvant. The peptides used corresponded to the following HAV amino acid sequences from published alignments (Cohen et al., 1987 a) : VP 1 10 to 30; VP2 40 to 60; VP3 31 to 47; all of VP4. The murine MAb, K24F2 (MacGregor et at., 1983) , is known to select HAV escape mutants with a substitution of histidine for aspartic acid at position 70 in VP3.
Synthesis of HA V subgenomic RNA transcripts. Production of RNA transcripts was essentially as described by Nielsen & Shapiro (1986) . Plasmid DNA (10 ~tg) was linearized with specific restriction enzymes as indicated in Results, extracted with phenol and chloroform, and ethanol-precipitated. Transcription in vitro was carried out using 45 units ofT7 RNA polymerase (Promega Biotech) for 2 h at 40 °C in the presence of 40 mM-Tris-HC1 pH 7.5, 6 mM-MgC12, 2 mM-spermidine, 1 mM-rNTPs, 10 mM-dithiothreitol and 50 units of RNasin (Promega Biotech). After transcription, template DNA was removed by incubation with 10 units of RNase-free DNase (RQI DNase; Promega Biotech) for 15 rain at 37°C. Transcripts were then phenol-and chloroform-extracted, ethanol-precipitated and stored at -70 °C.
Translation of RNA in vitro. Nuclease-treated rabbit reticulocyte lysate (Pelham & Jackson, 1976) was purchased from Promega Biotech. RNA transcripts (1 ~tg) were added to 36 ixl lysate containing 20 ~tmol of an amino acid mixture (without methionine) and 1 mCi/ml [35S]methionine (Amersham) in a total volume of 50 ~tl. The mixture was incubated for 60 min at 30 °C after which samples were treated with 10 ~tg RNase A before electrophoresis on 10~ polyacrylamide gels by standard methods (Laemmli, 1970) . After electrophoresis gels were treated with Amplify (Amersham), dried and exposed to X-ray film.
Immunoprecipitation of translation products. After incubation for 60 min at 30 °C, the translation mix was diluted 10-fold with NTE buffer/0.1% NP40 (150 mM-NaC1, 50 mM-Tris HCI pH 8, lmM-EDTA and 0.1 ~ NP40). Aliquots of 50 ial were taken, to which 1 jal of relevant antiserum was added, and stored overnight at 4 °C. Protein A (1 ~, 100 ~tl) (Pansorbin; Calbiochem), washed three times in NTE buffer/0.1 ~ NP40, was added and the mix was incubated for 2 h at 20°C. The Protein A pellet was washed three times in NTE buffer/0.1% N P40, resuspended in Laemmli loading buffer (Laemmli, 1970) and separated on polyacrylamide gels as described previously.
In some experiments translation products were denatured prior to immunoprecipitation by boiling in the presence of 1% SDS and then diluted to give a concentration of less than 0-I~ SDS before the addition of antisera. The remaining steps were as described above.
Results

RNA transcripts
Clone pTZ-T1 was linearized with specific restriction enzymes and RNA transcripts were produced using T7 RNA polymerase. As shown in Fig. 1 , linearization with BgllI produced a transcript terminating in the middle of the VP3 coding sequence, whereas transcripts from BamHI-linearized pTZ-T1 terminated near the amino terminus of VP1 and those from EcoRI-linearized pTZ-T1 represented virtually the entire P1 region except for 39 amino acids of the carboxy terminus. RNA transcripts were analysed by 1 ~ SDS-agarose gel electrophoresis to assess their quality. Fig. 2 shows an ethidium bromide-stained I ~ SDS-agarose gel of the transcripts, showing that they were of the expected size and each consisted of a discrete RNA species. These transcripts were used to programme in vitro translation in rabbit reticulocyte lysates.
In vitro translation of subgenomic transcripts
Previous work studying the in vitro translation of picornavirus RNA has shown that for poliovirus, accurate initiation of translation is highly dependent both on cellular factors and on the presence of the 5' NTR (Dorner et al., 1984) . However, in the absence of the 5' NTR, accurate initation of translation has been shown to occur in subgenomic transcripts of several picornaviruses (Clarke & Sangar, 1988; Nicklin et al., 1987) . It was therefore of importance to study the ability of our HAV transcripts to translate efficiently in vitro in the absence of the 5' NTR. Fig. 3 shows that the restriction enzyme-linearized transcripts translated well and yielded major products of the expected 3). Translation was initiated efficiently from the correct A U G even though only eight nucleotides of viral 5' N T R were present. Minor translation products were seen which were probably due to premature termination of translation; minor products of similar size were produced from different transcripts, e.g. compare Fig. 3 , lanes 2 and 3, in which a doublet of approximately 42K and 46K can be seen. Another minor species of approximately 65K could be seen following translation of the EcoRI-linearized transcript. These minor translation products are reproducible and are present after in v#ro translation of transcripts of differing lengths so it may be reasonable to assume that they are the result of secondary structural features within the R N A which lead to interruption of ribosomal translocation and allow premature termination.
Immunoprecipitation of translation products
In vitro translation products from BgllI-linearized transcripts were analysed by immunoprecipitation of 3sS-labelled products using guinea-pig antivirion serum or guinea-pig sera raised against specific H A V peptides (Fig. 4) . Antivirion antiserum (lane 3) and antipeptide antiserum against VP2 (lane 5), VP3 (lane 6) and VP4 (lane 7) each specifically precipitated a protein consistent with the full-length translation product expected from this transcript. In contrast, no material was precipitated with antipeptide VP1 antiserum (lane 4), consistent with the lack of VP1 sequences in this immunoprecipitated with a variety of antisera. Samples in lanes 7 to 12 were treated with SDS prior to immunoprecipitation, those in lanes 1 to 6 were not. Lanes 2 and 8, guinea-pig pre-immune serum; lanes 3 and 9, guinea-pig anti-HAV antiserum; lanes 4 and 10, murine MAb K24F2; lanes 5 and 11, guinea-pig antipeptide VP4 antiserum; lanes 6 and 12, human convalescent anti-HAV serum. Lanes 1 and 7 contain no antisera; lane M, polypeptide markers.
transcript. Similar results were obtained when the translation products of the BamHI-and EcoRI-linearized transcripts were immunoprecipitated, except that antipeptide antisera against VPI amino acids 10 to 30 did immunoprecipitate a product of the predicted size, consistent with the inclusion of VP1 sequences in these RNAs (data not shown).
Conformational studies of translation products
Since antibodies elicited by virus particles appeared to recognize determinants which are highly dependent on tertiary structure, the conformational dependence of the reaction of the in vitro translation products with various antisera was investigated. Immunoprecipitation experiments were performed as above except that the translation products were denatured by boiling in 1 SDS prior to the addition of antisera; this treatment did not affect recognition by antipeptide antisera (Fig. 4 , lanes 11 to 14). In contrast, precipitation with antivirion antiserum was totally abolished (Fig. 4, lane 10) .
In further experiments, the conformation independence of recognition of the translation products by antipeptide antisera was confirmed with an antipeptide VP4 antiserum (Fig. 5, lanes 5 and 11) and the conformation dependence of recognition by human, as well as guinea-pig, antivirion antisera was demonstrated (Fig. 5, lanes 3, 6, 9 and 12) . Although the same appeared to be true for MAb K24F2 (Fig. 5, lanes 4 and 10) , this result is equivocal because the precipitation of undenatured product with this antibody was only slightly greater than the non-specific precipitation seen in the absence of antibody or in the presence of control serum (Fig. 5, lanes, 1, 2, 7 and 8 ).
Discussion
This work has shown that subgenomic HAV transcripts translate well in the absence of all but eight nucleotides of the virus 5' NTR. The subgenomic constructs reported here were translated faithfully in an in vitro system, the major protein product in each case having the predicted Mr. Moreover, these products were precipitated with appropriate antipeptide antisera in a denaturationindependent manner. However, reactions with antipeptide antisera are probably biologically irrelevant because, of a panel of antisera raised to more than 50 different HAV peptides in this laboratory, none precipitated or neutralized the virus, although most recognized the appropriate virus proteins by Western blotting (D. Sangar & E. Amphlett, unpublished observations). In fact the only peptide reported to elicit virus-neutralizing activity represents part of the N terminus of VP 1 (Emini et al., 1985) and the mechanism of this activity is unclear because, by analogy with the structures of other picornaviruses, this sequence is probably located on the inside of the particle (Hogle et al., 1985) .
Both human and guinea-pig anti-HAV antisera precipitated the in vitro translation products of all three transcripts. However this reaction was totally eliminated when the antigens had been denatured by boiling with SDS, suggesting that the antibodies present in these antisera only recognized conformation-dependent epitopes. This is consistent with the observation that the antivirion sera used here do not recognize the virus proteins in a Western blot assay. A virus-neutralizing MAb, K24F2, also appeared to precipitate the EcoRIlinearized transcript translation product only in the undenatured state. However, the MAb precipitated less material than the polyclonal antisera and the occurrence of some non-specific precipitation in the control sample throws doubt on this observation. The fact that antivirion antisera precipitated translation products of the BgllI-tinearized runoff transcript, which does not encode VP1, is consistent with the view that residues surrounding aspartic acid 70 of VP3 contribute fundamentally to the dominant antigenic site of HAV. Therefore other sites of escape mutations identified in VP1 (Ping et al., 1988; L.-H. Ping & S. Lemon, unpublished observations) are not essential to the creation of a conformation-dependent HAV antigen.
The strong conformation dependence of the neutralization sites of HAV is further demonstrated by the inability of fusion proteins expressed in bacteria to elicit virus-neutralizing antibodies (Ostermayr et al., 1987; Johnston et al., 1988) . These fusion proteins were, however, detectable by Western blot assay using antiviral antisera. Since some antiviral antisera have been reported to recognize synthetic peptides, the reactions of the fusion proteins in Western blot analysis may be due to the presence of antibodies in the antisera used which recognize linear epitopes. Fusion proteins have been reported to prime animals for a subsequent anamnestic response to subimmunogenic doses of virus (Johnston et al., 1988; Gauss-Muller et al., 1990) . This is probably due to priming of T helper cells by HAV-specific epitopes present in the fusion proteins. The results presented here clearly show that proteins representing incomplete copies of the structural region of HAV can fold in such a way as to present conformational epitopes. Although not proven, it is possible that these epitopes resemble those present on the intact virus particle. This is supported by the recently reported observation that a recombinant vaccinia virus expressing a protein equivalent to that encoded by the BamHI fragment used in our work can elicit virus-neutralizing and protective antibodies in marmosets (Karayiannis et al., 1991) .
The apparent presence of conformation-dependent epitopes related to those present on virus particles is surprising because all of the translation products were incomplete representations of the natural structural protein precursor protein. Furthermore, none of the processing cleavages which normally separate the individual capsid proteins had occurred. However, the results do lend encouragement to the concept of producing a subunit vaccine against hepatitis A by recombinant DNA techniques.
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